Macroautophagy and Chaperone-Mediated Autophagy in Heart Failure: The Known and the Unknown

Rajeshwary Ghosh1, J Scott Pattison1

  • 1Division of Basic Biomedical Sciences, University of South Dakota Sanford School of Medicine, Vermillion, SD, USA.

Insights

Autophagy, a cellular cleaning process, plays a critical role in heart health by removing damaged components. Understanding its complex roles in cardiac diseases may unlock new therapeutic strategies.

Area of Science:

  • Cardiovascular Biology and Disease
  • Cellular Biology
  • Molecular Medicine

Background:

  • Cardiac diseases are increasingly linked to the accumulation of misfolded proteins and damaged organelles.
  • Autophagy, a key protein degradation pathway, is vital for cellular homeostasis and clearing cellular damage.

Purpose of the Study:

  • To review the major types of autophagic processes (macroautophagy, chaperone-mediated autophagy, selective mitophagy) and their regulation in cardiac physiology and pathology.
  • To discuss genetic models, markers, and methods for studying autophagy in the heart.
  • To summarize current research on autophagy's dual role in cardiac pathology and its therapeutic potential.

Main Methods:

  • Comprehensive literature review of autophagic processes, their regulation, and roles in cardiac disease.
  • Analysis of genetic models for studying autophagy.
  • Discussion of methods and markers for assessing autophagic activity in cardiac tissues.

Main Results:

  • Autophagy encompasses macroautophagy, chaperone-mediated autophagy, and selective mitophagy, each with distinct structures and functions.
  • Studies show conflicting results regarding macroautophagy's role, suggesting both cardioprotective and detrimental effects in heart failure.
  • Autophagy markers and measurement methods are crucial for interpreting its activity in cardiac pathology.

Conclusions:

  • Autophagy plays a significant and complex role in cardiac health and disease.
  • Further understanding of autophagy regulation is essential for developing novel therapeutic interventions for cardiac conditions.
  • Targeting autophagy pathways may offer a new therapeutic avenue for treating heart diseases.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
951
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
395
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
360